MedPath

Development of an Adaptive Treatment for Weight Loss in People with Prediabetes

Not Applicable
Completed
Conditions
PreDiabetes
Obesity
Interventions
Behavioral: Reduced Carbohydrate Diet
Behavioral: High Carbohydrate Diet
Registration Number
NCT04745572
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

This 16-week study will use an experimental approach called the Sequential Multiple Assignment Randomized Trial to help determine which combination and sequence of weight loss program features are most effective in people who are at risk for type 2 diabetes. Participants in the study will be initially randomized to consume either a high or reduced carbohydrate diet. After 4 weeks, participants will be identified as Responders (greater than or equal to 2.5% weight loss) or Non-Responders (less than 2.5% weight loss). Responders will continue with their initial randomized group for the remainder of the trial. Non-responders will be re-randomized to 2nd stage interventions of either including additional exercise counseling and training or beginning a time restricted eating protocol for the remainder of the trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • 18-75 years of age
  • BMI of 27 kg/m2 or greater
  • at risk for developing type 2 diabetes (prediabetes)
Read More
Exclusion Criteria
  • Pregnant, planning to become pregnant, or breastfeeding
  • uncontrolled hypo or hyperthyroidism
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Reduced Carbohydrate DietReduced Carbohydrate DietEnrollment in a group-based behavioral weight loss intervention based on the Diabetes Prevention Program curriculum with reduced carbohydrate diet plan.
High Carbohydrate DietHigh Carbohydrate DietEnrollment in a group-based behavioral weight loss intervention based on the Diabetes Prevention Program curriculum with high carbohydrate diet plan.
Primary Outcome Measures
NameTimeMethod
Change in insulinweek 16 visit

Serum insulin will be measured in a fasted state.

Changes in body weightweek 16 visit

Measured on digital scale at final visit.

Change in glucoseweek 16 visit

Serum glucose will be measured in a fasted state.

Changes in lipidsweek 16 visit

Fasting serum concentrations of total cholesterol, HDL cholesterol, triglycerides, and LDL cholesterol

Changes in fat massweek 16 visit

As measured by bioelectrical impedance analysis (BIA) on the InBody S10 body composition analyzer.

Changes in QUICKI indexweek 16 visit

Predictor of insulin resistance that will be calculated from glucose and insulin measures

Secondary Outcome Measures
NameTimeMethod
Changes in overall strengthweek 16 visit

As measured by hand grip dynamometry

Changes in aerobic fitnessweek 16 visit

As measured by the 3-minute step test.

Diet Intake and Physical Activity Monitoringweek 16 visit

7-day food logs and weekly physical activity logs

Trial Locations

Locations (1)

UAB Highlands Family and Community Medicine Clinic

🇺🇸

Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath